中国临床药理学杂志2025，Vol.41Issue(2)：263-263,1.
基于mRNA-IncRNA特征,高危、可手术、三阴性乳腺癌患者的强化化疗与标准化疗
Intensive chemotherapy versus standard chemotherapy among patients with high risk,operable,triple negative breast cancer based on integrated mRNA-lncRNA signature(BCTOP-T-A01):Randomised,multi-centre,phase 3 trial
引用本文复制引用
HE M..基于mRNA-IncRNA特征,高危、可手术、三阴性乳腺癌患者的强化化疗与标准化疗[J].中国临床药理学杂志,2025,41(2):263-263,1.
